Table 2.
Cancer type | Cases in NSWCR | Cases in APDC | PPV | Sensitivity | Specificity |
---|---|---|---|---|---|
Bladder | 523 | 1253 | 35% | 84% | 99.7% |
Breast | 4172 | 4376 | 86% | 90% | 99.8% |
Colorectal | 3597 | 3747 | 91% | 95% | 99.9% |
Kidney | 575 | 616 | 85% | 91% | 100.0% |
Lung | 1225 | 1151 | 86% | 81% | 100.0% |
Melanoma | 3748 | 2459 | 71% | 47% | 99.8% |
Non-Hodgkin Lymphoma | 1003 | 1080 | 71% | 76% | 99.9% |
Pancreatic | 271 | 283 | 81% | 84% | 100.0% |
Prostate | 7256 | 6401 | 86% | 76% | 99.7% |
Stomach | 282 | 314 | 78% | 87% | 100.0% |
Unknown primary | 306 | 659 | 29% | 62% | 99.8% |
Uterine | 543 | 535 | 93% | 92% | 100.0% |
APDC Admitted Patient Data Collection, NSWCR New South Wales Cancer Registry, PPV Positive predictive value